How is Ecnoglutide taken?

Ecnoglutide is typically administered by the subcutaneous route. Prescription medicine in China, dosed once weekly by a clinician. No self-directed protocol exists outside that.

What are the risks of Ecnoglutide?

Approved in China only — not authorised by the FDA, MHRA or EMA GI side effects are the common ones for the GLP-1 class, especially during escalation Trial data is in Chinese populations; results may not transfer directly Anything sold outside a Chinese pharmacy is not this product

Ecnoglutide

XW003 Sciwind

A once-weekly cAMP-biased GLP-1 receptor agonist. Approved in China for chronic weight management and for type 2 diabetes; not approved in the US, UK or EU.

Half-life: Not established
Out of system: —
Route: Subcutaneous
Level: Advanced

What Ecnoglutide is used for

cAMP-biased signalling is designed to hold efficacy with less receptor desensitisation than conventional GLP-1 agonism
Reported 15.1% placebo-adjusted mean weight loss in Chinese registrational trials
Once-weekly subcutaneous dosing

How it's typically used

Prescription medicine in China, dosed once weekly by a clinician. No self-directed protocol exists outside that.

What to watch for

Approved in China only — not authorised by the FDA, MHRA or EMA
GI side effects are the common ones for the GLP-1 class, especially during escalation
Trial data is in Chinese populations; results may not transfer directly
Anything sold outside a Chinese pharmacy is not this product

Common questions

How is Ecnoglutide taken?: Ecnoglutide is typically administered by the subcutaneous route. Prescription medicine in China, dosed once weekly by a clinician. No self-directed protocol exists outside that.
What are the risks of Ecnoglutide?: Approved in China only — not authorised by the FDA, MHRA or EMA GI side effects are the common ones for the GLP-1 class, especially during escalation Trial data is in Chinese populations; results may not transfer directly Anything sold outside a Chinese pharmacy is not this product

About GLP-1 & weight loss

What they are: Incretin analogues — GLP-1 and dual/triple agonists. They slow stomach emptying and act on appetite centres in the brain, so you eat less without white-knuckling it.
How they're run: One subcutaneous shot a week for most, on the same day each week. Doses climb in steps every four weeks; that slow titration is what keeps side effects tolerable.
What to watch: Nausea, constipation, and reflux are near-universal in the first month. Muscle is lost alongside fat unless you keep protein high and keep lifting. Tell any surgeon or anaesthetist you are on one.

Other glp-1 & weight loss

Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.